Person:
DURAN, RABİA

Profile Picture

Status

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

First Name

RABİA

Last Name

DURAN

Name

Email Address

Birth Date

Filters

20221
Reset filters

Settings

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    The Effect of Type 2 Diabetes Mellitus on the Development of Alzheimer's Disease and Its Molecular Mechanism
    (2022-01-01T00:00:00Z) DURAN, RABİA; Pancur, Sumeyra; BAHADORİ, FATEMEH; DURAN, RABİA; BAHADORİ, FATEMEH
    Following increased epidemiological studies indicating the relationship between diabetes and Alzheimer-s disease (AD), Type 2 diabetes has been reported to be a risk factor for the progress of AD pathology. Insulin resistance that develops in the brain, impairment in the insulin signal delivery system and glucose metabolism have been shown among the most likely pathophysiological causes of AD. It has been reported that the increase in AD markers such as phospho tau and A beta in the type 2 diabetes model of rats is associated with the decrease in the insulin receptor (IR) signaling and insulin-like growth factor-1 receptors (IGF-1R) ratio. Furthermore, intracellular components such as phospho-AKT (protein kinase B) and phospho-glycogen synthase kinase-3 beta (GSK3 beta), which are members of IR pathway, have been proved to be reduced in AD. Due to the common molecular mechanisms underlying the pathological development of Type 2 Diabetes and AD, treatment protocols indicated in diabetes have been used in the treatment of AD.